Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues
Science · 09.07.2026 · 393 (6807) · 188-194
DOI: 10.1126/science.aef5391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 09.07.2026. Verfasst von Samuel Ojeda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Degrons, Histone Acetyltransferases, Proteolysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Damon Runyon Cancer Research Foundation.
Abstract (Originalsprache)
Lysine acetyltransferases (KATs) cooperate with oncogenes such as c-Myc, estrogen receptor, and lysine methyltransferase 2A (KMT2A) fusions to sustain malignant programs. Targeting of KAT proteins has shown clinical efficacy; however, achieving homolog selectivity for most KATs remains a major challenge. By extending cereblon (CRBN)–based molecular glues beyond the canonical degron space, we developed an exquisitely selective degrader of KAT2A. Cryo–electron microscopy revealed that CRBN recruits KAT2A independently of a degron; instead, the molecular glue engages a surface-exposed tyrosine, mimicking antibody-like molecular recognition. Selective KAT2A degradation leads to potent ablation of histone H3 lysine 9 acetylation (H3K9Ac), antiproliferative effects in acute myeloid leukemia cell lines, and in vivo efficacy in a patient-derived xenograft model, establishing KAT2A as a targetable vulnerability to treat a wide range of malignancies. More generally, degron-independent recruitment extends the CRBN-targetable proteome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Samuel Ojeda, Meng Wang, Kheewoong Baek, Wallace Bourgeois, Alba Sommerschield, Hong Yue, Rebecca J Metivier, Panos Karagiannis, Talya S Levitz, Yuan Xiong, Katherine A Donovan, Scott A Armstrong, Eric S Fischer
Förderung
- NCI NIH HHS
- National Institutes of Health
- Damon Runyon Cancer Research Foundation
Zitieren
APA
Ojeda, S., Wang, M., Baek, K., Bourgeois, W., Sommerschield, A., Yue, H., Metivier, R. J., Karagiannis, P., Levitz, T. S., Xiong, Y., Donovan, K. A., Armstrong, S. A., & Fischer, E. S. (2026). Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues. Science, 393(6807), 188-194. https://doi.org/10.1126/science.aef5391
Vancouver
Ojeda S, Wang M, Baek K, Bourgeois W, Sommerschield A, Yue H, et al. Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues. Science. 2026;393(6807):188-194. doi:10.1126/science.aef5391
BibTeX
@article{Ojeda2026,
author = {Ojeda, Samuel and Wang, Meng and Baek, Kheewoong and Bourgeois, Wallace and Sommerschield, Alba and Yue, Hong and Metivier, Rebecca J and Karagiannis, Panos and Levitz, Talya S and Xiong, Yuan and Donovan, Katherine A and Armstrong, Scott A and Fischer, Eric S},
title = {Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues},
journal = {Science},
year = {2026},
volume = {393},
number = {6807},
pages = {188--194},
doi = {10.1126/science.aef5391}
}
EUVIMED